Stanford Institute for Stem Cell Biology and Regenerative Medicine
Higher EducationCalifornia, United States11-50 Employees
Stanford Institute for Stem Cell Biology and Regenerative Medicine.
Innovative Research Collaboration The partnership between Stanford Medicine and UCLA Health to conduct virtual simulations of obstetric emergencies indicates a focus on cutting-edge healthcare technology and collaborative research, presenting opportunities for sales of simulation software, medical training platforms, and collaborative research tools.
Digital and Data Adoption Stanford’s launch of The Digitalist Papers and active engagement in digital economy discussions highlight a strong interest in AI and digital transformation, suggesting potential for sales of AI-enabled analytics, research management solutions, and digital communication platforms.
Community Engagement The collaboration with Nuestra Casa on community outreach projects like SAFER Bay demonstrates a commitment to social impact and local engagement, opening avenues for solutions related to community health initiatives, outreach programs, and educational technology.
Environmental and Sustainability Focus Participation in COP30 and research on regeneratively grown staple foods for school meal programs reveal an emphasis on sustainability and environmental research, indicating potential sales opportunities for sustainability platforms, environmental monitoring tools, and eco-inclusive research solutions.
Emerging Funding and Growth Potential Although the company has modest revenue between 1M and 10M, its involvement in large-scale partnerships and global conferences suggests an evolving funding landscape, ideal for offering grant management software, research funding solutions, or engagement platforms for academic collaborations.
Stanford Institute for Stem Cell Biology and Regenerative Medicine uses 8 technology products and services including jsDelivr, Blackbaud, Vizient, and more. Explore Stanford Institute for Stem Cell Biology and Regenerative Medicine's tech stack below.
| Stanford Institute for Stem Cell Biology and Regenerative Medicine Email Formats | Percentage |
| FLast@stanford.edu | 50% |
| First.Last@stanford.edu | 17% |
| FirstL@stanford.edu | 5% |
| Last@stanford.edu | 4% |
| FirstLast@stanford.edu | 4% |
| LastFirst@stanford.edu | 3% |
| F.Last@stanford.edu | 2% |
| First@stanford.edu | 1% |
| F_Last@stanford.edu | 2% |
| F-Last@stanford.edu | 1% |
| LastF@stanford.edu | 1% |
| First.L@stanford.edu | 1% |
| First-Last@stanford.edu | 1% |
| First_Last@stanford.edu | 1% |
| FirLast@stanford.edu | 1% |
| FiLast@stanford.edu | 1% |
| First_L@stanford.edu | 1% |
| FirstLas@stanford.edu | 1% |
| Last.F@stanford.edu | 1% |
| FirstLa@stanford.edu | 1% |
| First.Middle@stanford.edu | 1% |
Higher EducationCalifornia, United States11-50 Employees
Stanford Institute for Stem Cell Biology and Regenerative Medicine.
Stanford Institute for Stem Cell Biology and Regenerative Medicine's revenue is estimated to be in the range of $1M$10M
Stanford Institute for Stem Cell Biology and Regenerative Medicine's revenue is estimated to be in the range of $1M$10M